Adverse events376

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 376

Type	Event	Organ system	Group	Affected	At risk
other	Anaemia	Blood and lymphatic system disorders	Group P; mFOLFOX6 + Panitumumab Combination Therapy	37	404
other	Anaemia	Blood and lymphatic system disorders	Group B; mFOLFOX6 + Bevacizumab Combination Therapy	50	407
other	Constipation	Gastrointestinal disorders	Group P; mFOLFOX6 + Panitumumab Combination Therapy	92	404
other	Constipation	Gastrointestinal disorders	Group B; mFOLFOX6 + Bevacizumab Combination Therapy	105	407
other	Diarrhoea	Gastrointestinal disorders	Group P; mFOLFOX6 + Panitumumab Combination Therapy	146	404
other	Diarrhoea	Gastrointestinal disorders	Group B; mFOLFOX6 + Bevacizumab Combination Therapy	135	407
other	Nausea	Gastrointestinal disorders	Group P; mFOLFOX6 + Panitumumab Combination Therapy	158	404
other	Nausea	Gastrointestinal disorders	Group B; mFOLFOX6 + Bevacizumab Combination Therapy	160	407
other	Stomatitis	Gastrointestinal disorders	Group P; mFOLFOX6 + Panitumumab Combination Therapy	249	404
other	Stomatitis	Gastrointestinal disorders	Group B; mFOLFOX6 + Bevacizumab Combination Therapy	165	407
other	Vomiting	Gastrointestinal disorders	Group P; mFOLFOX6 + Panitumumab Combination Therapy	43	404
other	Vomiting	Gastrointestinal disorders	Group B; mFOLFOX6 + Bevacizumab Combination Therapy	50	407
other	Fatigue	General disorders	Group P; mFOLFOX6 + Panitumumab Combination Therapy	158	404
other	Fatigue	General disorders	Group B; mFOLFOX6 + Bevacizumab Combination Therapy	162	407
other	Malaise	General disorders	Group P; mFOLFOX6 + Panitumumab Combination Therapy	63	404
other	Malaise	General disorders	Group B; mFOLFOX6 + Bevacizumab Combination Therapy	66	407
other	Pyrexia	General disorders	Group P; mFOLFOX6 + Panitumumab Combination Therapy	25	404
other	Pyrexia	General disorders	Group B; mFOLFOX6 + Bevacizumab Combination Therapy	48	407
other	Hypersensitivity	Immune system disorders	Group P; mFOLFOX6 + Panitumumab Combination Therapy	21	404
other	Hypersensitivity	Immune system disorders	Group B; mFOLFOX6 + Bevacizumab Combination Therapy	48	407

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02394795/events

API reference For AI assistants

Adverse events376

Sources 3

Read this list from software.